Hepatology and Gastroenterology

54 Items

All Items

Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling

Hongyan Zhang, Ruiqing Zong, Huiqi Wu, Jun Jiang, Chuanyong Liu, Suiyi Liu

1606–1619
The severity of intrahepatic cholestasis of pregnancy and its association with pregnancy complications and neonatal asphyxia: A single-center case analysis and systematic review

Siming Xin, Mengjiao Liu, Hua Lai, Liju Nie, Ying Hong, Yin Xiong, Xianxian Liu, Ting Wu, Xiaoming Zeng, Fen Fu

1501–1516
The role of the NY-ESO-1 in the prognosis of gastric cancer

Zvonimir Misir, Goran Glavčić, Suzana Janković, Ivan Kruljac, Jakša Čugura Filipović, Kristina Čimić, Monika Ulamec

813-820
Study on the mechanism of liver cancer immune escape mediated by MINDY1 through regulation of PD-L1 ubiquitination level

Xingchao Song, Wenjin Li, Chunyan Tian, Xiao Ma, Weibin Yang, Jiahua Zhou

144–154
Study on the mechanism of hyperoside in affecting the biological progression and radiosensitivity of esophageal carcinoma by modulating the STAT3/AKT/ERK pathway

Hongmei Yin, Zhongxia Yuan, Xiumei Han, Die Jiang, Duojie Li, FengLi Song

1150–1161
SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of S100A16 and activation of the PI3K/AKT signaling pathway

Hang Jiang, Zhiqian Xue, Liping Zhao, Boyuan Wang, Chenfei Wang, Haihan Song, Jianjun Sun

1231–1243
SKIL/SnoN attenuates TGF-β1/SMAD signaling-dependent collagen synthesis in hepatic fibrosis

Cheng Chi, Xifeng Liang, Tianyu Cui, Xiao Gao, Ruixia Liu, Chenghong Yin

1014–1025
Single-cell RNA sequencing reveals cellular dynamics and therapeutic effects of astragaloside IV in slow transit constipation

Huaxian Chen, Xingyang Wan, Qiulan He, Guozhong Xiao, Yihui Zheng, Minyi Luo, Chaoxin Yang, Donglin Ren, Li Lu, Hui Peng, Hongcheng Lin

871-887
Silencing METTL14 alleviates liver injury in non-alcoholic fatty liver disease by regulating mitochondrial homeostasis

Wei Wang, Jun Yan, Long Han, Zi-Lin Zou, Ai-Lei Xu

505–519
Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina

Nermin Salkić, Mirela Bašić Denjagić, Nađa Zubčević, Renata Tamburić, Azra Husić Selimović, Emil Babić, Milenko Bevanda, Aida Saray, Predrag Jovanović, Zoran Tošić, Aleksandar Dobrovoljski, Tatjana Barać

1400–1406
Risk factors and a nomogram for predicting valproic acid-induced liver injury : A nested case-control study

Yue Chen, Yadong Wang, Runan Xia, Yi Chen, Xuefeng Xie

1335–1344
Research progress on pathogenesis of skin pigmentation in chronic liver disease

Tianqi Liu, Tianyu Xi, Xiaoqin Dong, Dong Xu

1218–1232
Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis

Siqi Liu, Qian Zhang, Mengyao Zhang, Xuejing Zhong, Wudong Wang, Lishuang Wang, Zhenjing Jin

248–258
Quercetin regulates sensitivity to X-ray radiation of hepatocellular carcinoma through miR-216a-3p

Nuran Bedolla, Linyu Liu, Qiuxian Xie, Xueting Liu, Yanli Ren

833–849
Quercetin alleviates liver fibrosis via regulating glycolysis of liver sinusoidal endothelial cells and neutrophil infiltration

Xiaoying Chen, Yifan Wang, Jie Wan, Xiaoyun Dou, Chuzhao Zhang, Meng Sun, Fang Ye

1806–1815
Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis

Juncai Li, Jianguo Yang, Zhenzhou Chen, Li Liu, Hao Wang, Qican Deng, Yajun Chen, Yong Que, Zhongxue Fu

483–495
Promotive role of IRF7 in ferroptosis of colonic epithelial cells in ulcerative colitis by the miR-375-3p/SLC11A2 axis

Zepeng Chen, Qinglong Gu, Ruichao Chen

437–449
Prognostic evaluation in gallbladder carcinoma: Introducing a composite risk model integrating nutritional and immune markers

Si-qi Yang, Rui-qi Zou, Yu-shi Dai, Hai-jie Hu, Fu-yu Li

425–435
Predictive and prognostic value of preoperative pan-immune-inflammation value in patients with locally advanced rectal cancer

Peipei Shen, Yu Xu, Jiahao Zhu, Danqi Qian, Bo Yang, Yong Mao, Shengjun Ji, Ke Gu, Yutian Zhao

1000–1008
Prediction of pathologic complete response prediction in patients with locally advanced esophageal squamous cell carcinoma treated with neoadjuvant immunochemotherapy: A real-world study

Jifeng Feng, Liang Wang, Xun Yang, Qixun Chen, Xiangdong Cheng

153-160

1-20 of 54 Next